Triglyceride-glucose frailty index, metabolic-frailty phenotypes, and mortality in critically ill patients with acute kidney injury: Derivation, interpretation, and external validation.
Aug 2026· Experimental Gerontology· Vol 224, pp.
113291
· 0 citations· 46 references
Medicine
TL;DR
TyG-FI was consistently associated with mortality and delineated a reproducible lower-burden versus high frailty-organ dysfunction phenotype structure, which may support multidimensional risk characterization in ICU-AKI, although its incremental predictive advantage over FI-Lab alone or additive formulations was limited.
Abstract
Background
Prognosis remains heterogeneous among critically ill patients with acute kidney injury (AKI). We evaluated the triglyceride-glucose frailty index (TyG-FI), a composite of metabolic burden and laboratory-based frailty, for mortality risk characterization, phenotype identification, prediction, and external validation.
Methods
We included 2230 adults with KDIGO-defined AKI from MIMIC-IV. Associations between TyG-FI and ICU, in-hospital, 28-day, 90-day, and 365-day mortality were assessed using multivariable logistic and Cox regression, restricted cubic splines, subgroup analyses, and sensitivity analyses. Consensus clustering identified metabolic-frailty phenotypes. Twelve prediction algorithms were evaluated using a 7:3 development-test split, with SHAP and LIME for interpretation. Double machine learning was used as an exploratory robustness analysis. External model validation was performed in 1831 eICU patients, and phenotype reproducibility was assessed using independent clustering and transport of locked MIMIC-IV centroids.
Results
Higher TyG-FI was independently associated with ICU mortality (OR, 1.524; 95% CI, 1.377-1.686) and 28-day mortality (HR, 1.234; 95% CI, 1.146-1.330), with consistent associations for in-hospital, 90-day, and 365-day mortality. The primary K = 2 solution identified lower-burden and high frailty-organ dysfunction phenotypes, with 28-day mortality rates of 14.4% and 31.5%. In the held-out test set, logistic regression and CatBoost achieved AUROCs of 0.764 and 0.769, respectively. In eICU, the corresponding AUROCs were 0.694 and 0.667. Independently derived eICU phenotypes had 28-day mortality rates of 11.0% and 25.5%, while transported phenotypes had rates of 10.7% and 26.2%, with 95.4% agreement. Double-machine-learning estimates remained positive across sensitivity analyses.
Conclusions
TyG-FI was consistently associated with mortality and delineated a reproducible lower-burden versus high frailty-organ dysfunction phenotype structure. It may support multidimensional risk characterization in ICU-AKI, although its incremental predictive advantage over FI-Lab alone or additive formulations was limited.
Although CCI was the strongest individual predictor, the integrated model achieved the highest observed discrimination and its incremental benefit over some two-predictor models was modest and not statistically significant.
Kâmil Konur, Nurullah Parça, Bünyamin Onur Harmancı et al.· Journal of Clinical Medicine· 1 citation
Background Metabolic dysfunction-associated steatotic liver disease (MASLD), defined here by the lipid accumulation product (LAP), is common in middle-aged and older adults and linked to frailty, but factors driving frailty progression remain unclear. We examined the role of pain and depressive symptoms in incident fra...
Hui Hu, Ling Zhang, Xian-Bing Zhang et al.· Frontiers in Endocrinology· 0 citations
TyG-FI, which captures both metabolic dysfunction and physiological frailty, showed stronger associations with advanced CKM syndrome, prevalent CMM, and mortality than most surrogate insulin resistance indices, and may offer a pragmatic tool for early mortality risk stratification in individuals with high cardiometabol...
Kang Liu, Jia-Yuan Zhang, Hui He et al.· Cardiovascular Diabetology· 0 citations
CTI reliably predicts incident MCI in patients with CKM syndrome, the gradient boosting framework provides a robust risk stratification, and higher cognitive reserve may attenuate CTI-associated cognitive risk.
Hao Du, Ping Zhao, Zhe Yang et al.· Journal of Endocrinological...· 0 citations
Chronic kidney disease (CKD) represents a growing worldwide health concern. There is a need for easily obtainable markers that can improve risk evaluation in affected patients. Here, we investigated whether a laboratory‐derived frailty index (FI‐Lab) carries prognostic information for older CKD individuals admitted to...
Song-Li Zhou, Yi Yu· Health Science Reports· 0 citations
The interpretable XGBoost model effectively identified prevalent frailty in MHD patients, demonstrating strong discrimination, calibration, and clinical applicability, and may support systematic frailty screening and individualized assessment.
Jiao Wang, Ping Yu, Wen-Juan Sun et al.· Annals medicus· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.